期刊文献+

半标准剂量免疫球蛋白联合糖皮质激素治疗重症大疱性药疹疗效观察

Effective observation of sub-high dose intravenous immunoglobulin combined with corticosteroid in the treatment of severe bullous drug eruptions
下载PDF
导出
摘要 目的:观察半标准剂量免疫球蛋白联合糖皮质激素治疗Stevens-Johnson综合征(SJS)和中毒性表皮坏死松解症(TEN)的疗效。方法:回顾性分析2005年1月~2013年12月于我院皮肤科住院的35例重症大疱性药疹患者,采用SCORTEN评分系统评定疾病严重程度及预后。其中观察组17例,予半标准剂量(0.2g/kg·d)免疫球蛋白联合糖皮质激素治疗。对照组18例,仅予系统性糖皮质激素治疗。观察两组的最大糖皮质激素使用量、起效时间、热退时间、激素减量时间、住院时间,以及继发感染发生率和不良反应。结果:观察组的起效时间、热退时间、激素减量时间、住院时间明显低于对照组(P〈0.05);但两组之间最大糖皮质激素使用量无明显差异(P〉0.05);观察组的继发感染和不良反应发生率低于对照组(P〈0.05)。结论:半标准剂量免疫球蛋白联合糖皮质激素治疗较单纯激素治疗起效快,可加快糖皮质激素的减量,缩短住院时间,减少继发感染和不良反应。 Objective:To explore the efficacy for treating toxic epidermal necrolysis and Stevens-Johnson syndrome by half-standard dose intravenous immunoglobulin combining with corticosteroid. Methods:Retrospective analysis of clinical data was made in 35 cases of SJS and TEN from January 2005 to December 2013.The severity and prognosis of these patients can be evaluated by SCORTEN scoring system. 17 patients of the ovservation group were treated by half-standard dose(0.2g/kg·d)intravenous immunoglobulin in combination with corticosteroid.18 patients of the control group were treated with systemic corticosteroids only. The maximum amount of corticosteroid,onset time,fever relief time,corticosteroid reduction time,hospitalization time,the incidence of secondary infection,side effects were observed in two groups. Results:The onset time,fever relief time,corticosteroid reduction time and hospitalization time of the ovservation group were significantly lower than the control group(P0.05);But there was no significant difference in the maximum amount of corticosteroid between the two groups(P0.05);The incidence of secondary infection and side effects that in the ovservation group is lower than in the control group. Conclusion:Compared with the therapy by systemic corticosteroids alone,the therapy by halfstandard dose intravenous immunoglobulin combined with corticosteroid is more quickly effective,that can accelerate corticosteroid reduction,shorten the hospitalization time,reduce the incidence of secondary infection and side effects.
出处 《北方药学》 2015年第8期102-103,共2页 Journal of North Pharmacy
基金 2013年度佛山市卫生局医学科研立项课题项目编号:2013039
关键词 中毒性表皮坏死松解症 STEVENS-JOHNSON综合征 免疫球蛋白 半标准剂量 toxic epidermal necrolysis Stevens-Johnson syndrome Immunoglobulin Half-standard dose
  • 相关文献

参考文献8

二级参考文献38

  • 1蒋爱玉,马东来,王宝玺.红皮病型药疹合并耐青霉素金黄色葡萄球菌败血症1例[J].临床皮肤科杂志,2005,34(4):244-244. 被引量:1
  • 2郭美姿,杜昌兰,刘燕,王春.老年人医院获得性金黄色葡萄球菌肺炎分析[J].实用老年医学,2007,21(3):189-191. 被引量:15
  • 3French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int, 2006, 55( 1 ): 9-16.
  • 4Paquet P, Pierard GE, Quatresooz P. Novel treatments for druginduced toxic epidermal necrolysis (Lyell's syndrome ). hat Arch Allergy Immunol, 2005, 136(3 ): 205-216.
  • 5Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol, 2000, 115(2): 149-153.
  • 6Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science, 1998, 282(5388): 490-493.
  • 7Stella M, Clemente A, Bollero D, et al. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis. Bums, 2007, 33(4): 452-459.
  • 8Viard I,Wehrli P,Bullani R,et al.Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin[J].Science,1998,282(5388):490-493.
  • 9Bachot N,Revuz J,Roujeau JC.Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis:a prospective noncomparative study showing no benefit on mortality or progression[J].Arch Dermatol,2003,139(1):33-36.
  • 10Mistry RD,Schwab SH,Treat JR.Stevens-Johnson syndrome and toxic epidermal necrolysis:consequence of treatment of an emerging pathogen[J].Pediatr Emerg Care,2009,25(8):519-522.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部